滑液LTF、PRTN3和MNDA作为假体周围感染有前景的生物标志物:四极杆轨道阱质谱鉴定
这项回顾性研究对前瞻性收集的50份滑液标本(髋20份、膝30份)进行四极杆轨道阱质谱分析,其中25例为无菌性松动(非PJI)、25例按MSIS标准诊断为PJI,比较蛋白表达差异,并用预测分析和随机森林模型筛选、ELISA在扩大队列中验证。结果发现LTF、PRTN3和MNDA是最有前景的蛋白,并报告了各自的AUC。
要点
- 质谱诊断PJI的AUC:LTF 0.9888、PRTN3 0.9488、MNDA 0.9632。
- ELISA验证LTF、MNDA和PRTN3对PJI诊断敏感,LTF和MNDA具有特异性。
- 研究鉴定出1个既往已知蛋白和2个新候选蛋白作为滑液PJI生物标志物。
核心结论
- 该蛋白组学研究鉴定出1个既往已知蛋白和2个新候选蛋白作为有前景的滑液PJI诊断生物标志物,并建议在未来临床试验中进一步验证。
研究设计与样本
- 回顾性研究,样本为前瞻性收集,共50份术前滑液抽吸标本(髋20份、膝30份)。
- 25例诊断为无菌性松动(非PJI),25例按Musculoskeletal Infection Society标准诊断为PJI。
- 采用四极杆轨道阱质谱比较PJI与非PJI患者的蛋白表达,并用预测分析微阵列软件和随机森林模型确定最有效诊断PJI的蛋白。
- 对选出的最有前景蛋白,在扩大样本队列中用ELISA验证其表达改变。
- 证据等级为诊断性研究Level III。
主要发现
- 与无PJI患者相比,PJI患者滑液中有256种蛋白显著上调(≥3.0倍),14种蛋白下调。
- 最有前景的3种蛋白为乳铁蛋白(LTF)、多形核白细胞丝氨酸蛋白酶3(PRTN3)和髓系核分化抗原(MNDA)。
- 质谱诊断PJI的AUC:LTF为0.9888,PRTN3为0.9488,MNDA为0.9632。
- ELISA结果验证LTF、MNDA和PRTN3对PJI诊断敏感,而LTF和MNDA具有特异性。
关键数值与推荐
- PJI诊断依据Musculoskeletal Infection Society标准。
- 质谱诊断PJI的AUC:LTF 0.9888、PRTN3 0.9488、MNDA 0.9632。
临床怎么用
- LTF、PRTN3和MNDA作为滑液生物标志物,在质谱和ELISA中显示出对PJI诊断的潜力。
- 作者指出这些蛋白应在未来临床试验中进一步验证。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Diagnosing periprosthetic joint infection (PJI) requires various laboratory and clinical criteria. The purpose of this study was to explore novel biomarkers that could rapidly diagnose PJI with high accuracy. METHODS: In this retrospective study of prospectively collected samples, 50 synovial fluid aspirates, 20 from the hip and 30 from the knee, were collected before surgery; 25 of the patients were diagnosed as having aseptic loosening (non-PJI) and 25, as having PJI according to the Musculoskeletal Infection Society criteria. A quadrupole orbital-trap mass spectrometry (MS) instrument was used to compare expression of proteins in patients with and without PJI. Proteins that were most efficacious for diagnosis of PJI were then determined using prediction analysis of microarray software and a random forest model. The most promising proteins were selected, and altered expression of these selected proteins was verified by ELISA (enzyme-linked immunosorbent assay) in an extended sample cohort. RESULTS: A total of 256 proteins were significantly upregulated (≥3.0-fold) and 14 proteins were downregulated in synovial fluid of patients with PJI compared with patients without PJI. The 3 most promising proteins were lactoferrin (LTF), polymorphonuclear leukocyte serine protease 3 (PRTN3), and myeloid nuclear differentiation antigen (MNDA). When MS was used for diagnosis of PJI, the area under the curve was 0.9888 for LTF, 0.9488 for PRTN3, and 0.9632 for MNDA. ELISA results verified that LTF, MNDA, and PRTN3 were sensitive, while LTF and MNDA were specific, for diagnosis of PJI. CONCLUSIONS: This proteomic study identified a previously noted protein and 2 novel candidate proteins as promising synovial fluid biomarkers for PJI diagnosis, and they should be further validated in future clinical trials. LEVEL OF EVIDENCE: Diagnostic Level III. See Instructions for Authors for a complete description of levels of evidence.
引用
- Wang C, Wang Q, Li R, et al. LTF, PRTN3, and MNDA in Synovial Fluid as Promising Biomarkers for Periprosthetic Joint Infection: Identification by Quadrupole Orbital-Trap Mass Spectrometry. J Bone Joint Surg Am. 2019. PMID: 31644522. doi:10.2106/JBJS.18.01483
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。